![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
EFFICACY AND DURABILITY OF 2-DRUG VS 3-DRUG
INSTI-BASED REGIMENS: DATA FROM REAL-LIFE
|
|
|
CROI 2020
Reported by Jules Levin
Fabbiani M1, Rosse B1, Ciccullo A2, Oreni ML3, Lagi F4, Celani L5, Colafigli M6, De Vito A7, Tor, Dusina A2, Rusconi S3, CapeF A3, Sterran G4, d’EKorre G5, Di Giambenede S2.
1.Infectious Diseases Unit, Azienda Ospedaliero-Universitaria Senese, Siena, Italy; 2.Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy; 3.Infectious Diseases Unit, DIBIC Luigi Sacco, University of Milan, Milan, Italy;
4.Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; 5.Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy; 6.Infectious Dermatology and Allergology Unit, IFO S. Gallicano Institute (IRCCS), Rome, Italy;
7.Infectious Diseases Unit, Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy; 8.Department of Medical and Surgical Sciences, Unit of Infectious and Tropical Diseases, "Magna Graecia" University, Catanzaro, Italy.
![0330201](../images/033020/033020-10/0330201.gif)
![0330202](../images/033020/033020-10/0330202.gif)
![0330203](../images/033020/033020-10/0330203.gif)
![0330204](../images/033020/033020-10/0330204.gif)
![0330205](../images/033020/033020-10/0330205.gif)
![0330206](../images/033020/033020-10/0330206.gif)
![0330207](../images/033020/033020-10/0330207.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|